Shares of Colfax Corp. (NYSE:CFX) have received a consensus rating of “Hold” from the fifteen ratings firms that are currently covering the stock. Two investment analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation and five have issued a buy recommendation on the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $29.75.
Several research firms recently commented on CFX. Cowen and Company reiterated a “buy” rating on shares of Colfax Corp. in a research report on Friday, June 10th. Citigroup Inc. boosted their price objective on shares of Colfax Corp. from $25.00 to $26.00 and gave the stock a “sell” rating in a research report on Friday, July 29th. Zacks Investment Research downgraded shares of Colfax Corp. from a “hold” rating to a “sell” rating in a research note on Tuesday. Finally, Barclays PLC reissued an “equal weight” rating and issued a $28.00 target price (up previously from $26.00) on shares of Colfax Corp. in a research note on Monday, July 18th.
Shares of Colfax Corp. (NYSE:CFX) opened at 31.05 on Tuesday. Colfax Corp. has a 12 month low of $18.22 and a 12 month high of $33.63. The firm has a market capitalization of $3.81 billion, a PE ratio of 30.77 and a beta of 1.60. The stock has a 50 day moving average of $29.81 and a 200-day moving average of $28.89.
Colfax Corp. (NYSE:CFX) last released its quarterly earnings data on Thursday, July 28th. The company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.39 by $0.02. Colfax Corp. had a net margin of 3.23% and a return on equity of 5.55%. The business had revenue of $957.20 million for the quarter, compared to analyst estimates of $943.50 million. During the same period in the previous year, the firm earned $0.50 EPS. The business’s revenue for the quarter was down 6.6% compared to the same quarter last year. On average, equities research analysts anticipate that Colfax Corp. will post $0.71 EPS for the current fiscal year.
In related news, SVP A. Lynne Puckett sold 21,037 shares of the stock in a transaction that occurred on Friday, September 30th. The shares were sold at an average price of $31.00, for a total transaction of $652,147.00. Following the completion of the sale, the senior vice president now owns 20,370 shares of the company’s stock, valued at approximately $631,470. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 10.50% of the company’s stock.
A number of hedge funds have recently bought and sold shares of CFX. Eqis Capital Management Inc. acquired a new stake in Colfax Corp. during the third quarter worth about $217,000. Landscape Capital Management L.L.C. acquired a new stake in Colfax Corp. during the second quarter worth about $235,000. Hsbc Holdings PLC increased its stake in Colfax Corp. by 15.9% in the second quarter. Hsbc Holdings PLC now owns 9,214 shares of the company’s stock worth $244,000 after buying an additional 1,262 shares during the period. Pacer Advisors Inc. increased its stake in Colfax Corp. by 506.3% in the second quarter. Pacer Advisors Inc. now owns 10,229 shares of the company’s stock worth $270,000 after buying an additional 8,542 shares during the period. Finally, Jane Street Group LLC acquired a new stake in Colfax Corp. during the second quarter worth about $270,000. 78.33% of the stock is owned by hedge funds and other institutional investors.
About Colfax Corp.
Colfax Corporation is an industrial manufacturing and engineering company. The Company provides gas and fluid-handling and fabrication technology products and services to commercial and governmental customers around the world under Howden, ESAB and Colfax Fluid Handling brand names. The Company’s segments include Gas and Fluid Handling, and Fabrication Technology.
Receive News & Ratings for Colfax Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colfax Corp. and related companies with MarketBeat.com's FREE daily email newsletter.